‘Substantive evidence’ on HCV cure benefits

liver puzzle
Direct-acting antivirals are associated with reduced risk of mortality and liver cancer, according to results from the first prospective, longitudinal study investigating their use in treating chronic hepatitis C The research, published in The Lancet, is the first to demonstrate the clinical effectiveness of DAAs on the disease. It suggests that they should be considered

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 12 monitored medicines a minute
Next Professional misconduct – or not?